Shares of Johnson & Johnson, which rose till 1.44% over the past week, on Tuesday closed with a decrease of 2.3%, despite on the publication of a better-than-expected Wall Street experts, a report for 3 fin. quarter. Investors are concerned about the potential consequences of ending the large-scale study of the J&J vaccine against COVID-19, […]